RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tumor cells release exosomes containing RNA, which may serve as diagnostic biomarkers for thyroid cancer. This study identified specific RNA profiles in cancer-derived exosomes, highlighting potential new markers for early disease detection.
Area Of Science
- Molecular Biology
- Cancer Research
- Biomarker Discovery
Background
- Exosomes, extracellular vesicles from tumor cells, carry bioactive molecules like RNA.
- Analyzing exosomal RNA offers potential for novel diagnostic and prognostic tumor biomarkers.
- Radioiodine-refractory aggressive thyroid cancer lacks effective treatments, necessitating early detection biomarkers.
Purpose Of The Study
- To compare gene expression profiles of exosomes from non-tumorigenic and papillary thyroid cancer cell lines with their respective cell bodies.
- To identify specific RNA transcripts enriched in tumor-derived exosomes.
- To explore the potential of these exosomal RNAs as thyroid cancer biomarkers.
Main Methods
- Transcriptome analysis of exosomes and cell bodies from Nthy-ori 3.1 and TPC-1 cell lines.
- Differential gene expression analysis between exosomes and cell bodies.
- Gene ontology analysis to identify enriched pathways in exosomal RNA.
Main Results
- Significant differential expression of 9107 transcripts in TPC-1 exosomes vs. TPC-1 cells and 5861 in Nthy-ori 3.1 exosomes vs. Nthy-ori 3.1 cells.
- Upregulation of SIGLEC10, SIGLEC11, and KRTAP5-3 transcripts exclusively in TPC-1 exosomes.
- Enrichment of epigenetic process-related pathways associated with differentially expressed genes in TPC-1 exosomes.
Conclusions
- Specific mRNA species are selectively packaged into exosomes derived from tumor cells.
- Exosomal RNA profiles, particularly those related to epigenetic processes, show promise for thyroid tumor biomarker development.
- These findings provide a foundation for identifying novel diagnostic or prognostic biomarkers for thyroid cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...